Thrombosis Research
Volume 118, Issue 4 , Pages 433-438 , 2006

Occult bleeding in three different antithrombotic regimes after myocardial infarction: A WARIS-II subgroup analysis

Received 11 May 2005 ,Revised 1 July 2005 ,Accepted 28 July 2005.

References 

  1. Antithrombotic trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71–86
  2. Hurlen M, Abdelnoor M, Smith P, Erikssen J, Arnesen H. Warfarin, aspirin, or both after myocardial infarction. N Engl J Med. 2002;347:969–974
  3. van Es RF, Jonker JJ, Verheught FWA, Deckers JW, Grobbee DE. Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised, controlled trial. Lancet. 2002;360:109–113
  4. Anand SS, Yusuf S. Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis. JAMA. 1999;282:2058–2067
  5. Fiore LD, Ezekowitz MD, Brophy MT, Lu D, Sacco J, Peduzzi P. Department of Veterans Affairs Cooperative Studies Program Clinical Trial comparing combined warfarin and aspirin with aspirin alone in survivors of acute myocardial infarction: primary results of the CHAMP study. Circ. 2002;105:557–563
  6. Coumadin Aspirin Reinfarction Study (CARS) Investigators: randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction. Lancet. 1997;350:389–396
  7. Kolbe-Busch S, Lotz J, Hafner G, Blankaert NJC, Claeys G, Togni G, et al. Multicenter evaluation of a fully mechanized soluble transferrin receptor assay on the Hitachi and Cobas Integra analyzers. The determination of reference ranges. Clin Chem Lab Med. 2002;40(5):529–536
  8. Hurlen M, Erikssen J, Smith P, Arnesen H, Rollag A. Comparison of bleeding complications of warfarin and warfarin plus acetylsalicylic acid: a study in 3166 outpatients. J Int Med. 1994;236:299–304
  9. Greenberg PD, Cello JP, Rockey DC. Asymptomatic chronic gastrointestinal blood loss in patients taking aspirin or warfarin for cardiovascular disease. Am J Med. 1996;100:598–604
  10. Jaffin BW, Bliss CM, Lamont JT. Significance of occult gastrointestinal bleeding during anticoagulation therapy. Am J Med. 1987;83:269–272
  11. Kewenter J, Svanvik J, Svensson C, Wallgren K. The diagnostic value of the Hemocult as a screening test in patients taking anticoagulants. Cancer. 1984;54:3054–3058
  12. Culclasure TF, Bray VJ, Hasbargen JA. The significance of hematuria in the anticoagulated patient. Arch Intern Med. 1994;154:649–652
  13. Meade TW, Howarth DJ, Brennan PJ. Effects of low intensity antithrombotic regimes on the haemoglobin level. Thromb Haemost. 1993;71:284–285
  14. Goodman SG, Langer A, Durica SS, Rascob GE, Comp PC, Gray RJ, et al. Safety and anticoagulation effect of a low-dose combination of warfarin and aspirin in clinically stable coronary artery disease. Am J Cardiol. 1994;74:657–661

PII: S0049-3848(05)00348-8

doi: 10.1016/j.thromres.2005.07.023

Thrombosis Research
Volume 118, Issue 4 , Pages 433-438 , 2006

Article Tools